Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302а and -377 in tumor tissue.

Yu V Vitruk,S L Semko,O A Voylenko,M V Pikul,T V Borikun,T V Zadvornyi,T M Yalovenko,E O Stakhovsky, O V Rossylna

Experimental oncology（2021）

Cited 0|Views0

No score

Abstract

Levels of miR-99b, -210 and -377 expression in RCC tumor tissue might be used as a basis for future predictive panel intended for the assessment of the sensitivity to the regimens of neoadjuvant RCC treatment.

Translated text

Key words

renal cell carcinoma,renal cell carcinoma patients,tyrosine kinase inhibitors

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined